Compendium of Cancer Genome Aberrations

Volunteer Assignments and Opportunities: Difference between revisions

← Older editNewer edit →
VisualWikitext
No edit summary
Snehal.Patel (talk | contribs)
editor
270 edits
No edit summary
(90 intermediate revisions by 6 users not shown)
Line 4: Line 4:
|-
|-
!'''Disease'''!!'''Page Type'''!!'''Author'''
!'''Disease'''!!'''Page Type'''!!'''Author'''
!'''Date Assigned to Author (Target Completion Date)'''!!'''Associate Editor'''
!'''Date Assigned to Author'''
!'''Author Content Pending or Complete'''
!'''Target Completion Date'''
!'''Date Completed by Author'''
!'''Author Content (Pending or Complete)'''
!'''Editor Reviewed (Date of Last Review)'''
!'''Date Completed by Author'''!!'''Associate Editor'''
!'''Date of Last Editor Review'''
!'''Notes'''
!'''Notes'''
|-
|-
|'''''Myeloproliferative Neoplasms (MPN)'''''||'''''Overview'''''||Mark Evans (trainee), Fabiola Quintero-Rivera
|'''''Myeloproliferative Neoplasms (MPN)'''''||'''''Overview'''''||Mark Evans (trainee), Fabiola Quintero-Rivera
|
|
|complete
|
|
|Fabiola Quintero-Rivera (FQR)
|Fabiola Quintero-Rivera (FQR)
|PENDING
|
|
|
|
|
Line 20: Line 22:
|    Chronic Myeloid  Leukemia (CML), BCR-ABL1-Positive||Disease
|    Chronic Myeloid  Leukemia (CML), BCR-ABL1-Positive||Disease
|Mark Evans (trainee)+Jack Reid (trainee)+Fabiola Quintero-Rivera
|Mark Evans (trainee)+Jack Reid (trainee)+Fabiola Quintero-Rivera
|
|
|complete
|
|
|FQR
|FQR
|Complete
|
|
|
|
|
Line 29: Line 32:
|    Chronic Neutrophilic  Leukemia (CNL)||Disease
|    Chronic Neutrophilic  Leukemia (CNL)||Disease
|Anamaria Munteanu (trainee)+Fabiola Quintero-Rivera
|Anamaria Munteanu (trainee)+Fabiola Quintero-Rivera
|
|
|complete
|
|
|FQR
|FQR
|PENDING
|
|
|
|
|
Line 38: Line 42:
|    Polycythaemia Vera  (PV)||Disease
|    Polycythaemia Vera  (PV)||Disease
|Gokce A. Toruner
|Gokce A. Toruner
|
|
|complete
|
|
|FQR
|FQR
|PENDING
|
|
|
|
|
Line 48: Line 53:
|T. Niroshi  Senaratne
|T. Niroshi  Senaratne
|
|
|FQR
|PENDING
|
|
|complete
|
|
|FQR
|8/4/2020 before submission
|
|
|-
|-
|    Essential  Thrombocythaemia (ET)||Disease
|    Essential  Thrombocythaemia (ET)||Disease
|Rebecca Smith (trainee) + faculty TBD
|Rebecca Smith (trainee) + Fabiola Quintero-Rivera
|
|
|complete/pending faculty review
|
|
|FQR
|FQR
|PENDING
|
|
|
|
|
|-
|-
|    Chronic Eosinophilic  Leukemia, Not Otherwise Specified||Disease
|    Chronic Eosinophilic  Leukemia, Not Otherwise Specified||Disease
|Mark Evans (trainee), Fabiola Quintero-Rivera
|(trainee), Daynna J.Wolff
|
|
|pending faculty review
|
|
|FQR
|FQR
|PENDING
|
|
|
|
|
|-
|-
|    Myeloproliferative  Neoplasm (MPN), Unclassifiable||Disease
|    Myeloproliferative  Neoplasm (MPN), Unclassifiable||Disease
|Mark Evans (trainee)+ Fabiola Quintero-Rivera
|Thomas Lee
|8/17/2020
|9/7/2020
|complete
|
|
|FQR
|FQR
|PENDING
|
|
|
|
|
|-
|-
|'''''Mastocytosis'''''||'''''Overview'''''||
|'''''Mastocytosis'''''||'''''Overview'''''||'''Shashi Shetty, Ph.D.'''
| ||FQR
|
|
|
|
|complete
| ||FQR
|
|
|
|
|-
|-
|    Cutaneous  Mastocytosis||Disease
|    Cutaneous  Mastocytosis||Disease
|Thuy Phung
|Thuy Phung/Shuo-Shawn Liu
|
|
|complete/pending adding content online as of 2/4/21
|
|
|FQR
|FQR
|PENDING
|
|
|
|
|
Line 99: Line 110:
|    Systemic Mastocytosis||Disease
|    Systemic Mastocytosis||Disease
|Shashi Shetty
|Shashi Shetty
|
|
|complete
|
|
|FQR
|FQR
|PENDING
|
|
|
|
|
|-
|-
|    Mast Cell Sarcoma||Disease
|    Mast Cell Sarcoma||Disease
|Thuy Phung
|Thuy Phung +Jordan Lowery
|
|
|complete
|
|
|FQR
|FQR
|PENDING
|
|
|
|
|
|-
|-
|'''''Myeloid/Lymphoid Neoplasms with Eosinophilia and Rearrangement  of PDGFRA, PDGFRB or FGFR1, or with PCM1-JAK2'''''||'''''Overview'''''||Daynna J.Wolff
|'''''Myeloid/Lymphoid Neoplasms with Eosinophilia and Rearrangement  of PDGFRA, PDGFRB or FGFR1, or with PCM1-JAK2'''''||'''''Overview'''''||Daynna J.Wolff
|
|
|complete
|
|
|FQR
|FQR
|PENDING
|
|
|
|
|
Line 125: Line 139:
|    Myeloid/Lymphoid  Neoplasms with PDGFRA Rearrangement||Disease||Jay Alden  (trainee) +Daynna J.Wolff
|    Myeloid/Lymphoid  Neoplasms with PDGFRA Rearrangement||Disease||Jay Alden  (trainee) +Daynna J.Wolff
|
|
|FQR
|
|Complete
|Complete
|
|
|FQR
|
|
|
|
Line 133: Line 148:
|    Myeloid/Lymphoid  Neoplasms with PDGFRB Rearrangement||Disease||Christopher Sullivan (trainee) + Daynna J.Wolff
|    Myeloid/Lymphoid  Neoplasms with PDGFRB Rearrangement||Disease||Christopher Sullivan (trainee) + Daynna J.Wolff
|
|
|FQR
|
|Complete
|Complete
|
|
|FQR
|
|
|
|
Line 141: Line 157:
|    Myeloid/Lymphoid  Neoplasms with FGFR1 Rearrangement||Disease||Yanna Ding
|    Myeloid/Lymphoid  Neoplasms with FGFR1 Rearrangement||Disease||Yanna Ding
|
|
|FQR
|
|Complete
|Complete
|
|
|FQR
|
|
|
|
Line 149: Line 166:
|    Myeloid/Lymphoid  Neoplasms with PCM1-JAK2||Disease||Jessica Snider (trainee) + Daynna J.Wolff
|    Myeloid/Lymphoid  Neoplasms with PCM1-JAK2||Disease||Jessica Snider (trainee) + Daynna J.Wolff
|
|
|FQR
|
|Complete
|Complete
|
|
|FQR
|
|
|
|
Line 159: Line 177:
|Lauren R. Crowson (trainee)-Hindman + Daynna J. Wolff
|Lauren R. Crowson (trainee)-Hindman + Daynna J. Wolff
|
|
|FQR
|
|Complete
|Complete
|
|
|FQR
|
|
|NON-WHO ENTITY
|NON-WHO ENTITY
Line 169: Line 188:
|Lauren R. Crowson (trainee) + Daynna J. Wolff
|Lauren R. Crowson (trainee) + Daynna J. Wolff
|
|
|FQR
|
|Complete
|Complete
|
|
|FQR
|
|
|NON-WHO ENTITY
|NON-WHO ENTITY
Line 177: Line 197:
|'''''Myelodysplastic/Myeloproliferative Neoplasms (MDS/MPN)'''''||'''''Overview'''''||Linsheng Zhang
|'''''Myelodysplastic/Myeloproliferative Neoplasms (MDS/MPN)'''''||'''''Overview'''''||Linsheng Zhang
|
|
|FQR
|
|Complete
|Complete
|
|
|FQR
|
|
|
|
Line 185: Line 206:
|    Chronic  Myelomonocytic Leukemia (CMML)||Disease||Linsheng Zhang
|    Chronic  Myelomonocytic Leukemia (CMML)||Disease||Linsheng Zhang
|
|
|FQR
|
|Complete
|Complete
|
|
|FQR
|
|
|
|
Line 193: Line 215:
|    Atypical Chronic  Myeloid Leukemia (aCML), BCR-ABL1 Negative||Disease||Linsheng Zhang
|    Atypical Chronic  Myeloid Leukemia (aCML), BCR-ABL1 Negative||Disease||Linsheng Zhang
|
|
|FQR
|
|Complete
|Complete
|
|
|FQR
|
|
|
|
Line 201: Line 224:
|    Juvenile  Myelomonocytic Leukemia (JMML)||Disease||Sarah Rapisardo
|    Juvenile  Myelomonocytic Leukemia (JMML)||Disease||Sarah Rapisardo
|
|
|FQR
|9/1/20
|PENDING
|PENDING
|
|
|FQR
|
|
|
|
|-
|-
|     Myelodysplastic/Myeloproliferative Neoplasms with Ring Sideroblasts  and Thrombocytosis (MDS/MPN-RS-T)||Disease||Anamaria Munteanu (trainee)+Fabiola Quintero-Rivera
|     Myelodysplastic/Myeloproliferative Neoplasms with Ring Sideroblasts  and Thrombocytosis (MDS/MPN-RS-T)||Disease||Anamaria Munteanu (trainee)+Fabiola Quintero-Rivera
|
|
|complete
|
|
|FQR
|FQR
|PENDING
|
|
|
|
|
|-
|-
|     Myelodysplastic/Myeloproliferative Neoplasms (MDS/MPN), Unclassifiable||Disease||Ruth MacKinnon
|     Myelodysplastic/Myeloproliferative Neoplasms (MDS/MPN), Unclassifiable||Disease||Ruth MacKinnon
|
|
|complete
|
|
|FQR
|FQR
|PENDING
|
|
|
|
|
|-
|-
|'''''Myelodysplastic Syndromes (MDS)'''''||'''''Overview'''''||Teresa Smolarek?
|'''''Myelodysplastic Syndromes (MDS)'''''||'''''Overview'''''||Teresa Smolarek?
|
|9/1/20
|pending
|
|
|FQR
|FQR
|
|
|
|
|
|
Line 233: Line 260:
|    Myelodysplastic  Syndrome (MDS) with Single Lineage Dysplasia||Disease||Xiaoli Du(trainee) +Teresa Smolarek
|    Myelodysplastic  Syndrome (MDS) with Single Lineage Dysplasia||Disease||Xiaoli Du(trainee) +Teresa Smolarek
|
|
|FQR
|9/1/20
|PENDING
|PENDING
|
|
|FQR
|
|
|
|
Line 241: Line 269:
|    Myelodysplastic  Syndrome with Ring Sideroblasts (MDS-RS)||Disease||Xiaolin Hu(trainee)+Teresa Smolarek
|    Myelodysplastic  Syndrome with Ring Sideroblasts (MDS-RS)||Disease||Xiaolin Hu(trainee)+Teresa Smolarek
|
|
|FQR
|
|Complete
|Complete
|
|
|FQR
|
|
|
|
Line 249: Line 278:
|    Myelodysplastic  Syndrome with Ring Sideroblasts and Multilineage Dysplasia||Disease||Xiaolin Hu(trainee)+Teresa Smolarek
|    Myelodysplastic  Syndrome with Ring Sideroblasts and Multilineage Dysplasia||Disease||Xiaolin Hu(trainee)+Teresa Smolarek
|
|
|FQR
|
|Complete
|Complete
|
|
|FQR
|
|
|
|
|-
|-
|    Myelodysplastic syndrome with multilineage dysplasiaMyelodysplastic Syndrome (MDS) with  Multilineage Dysplasia||Disease||Xiaoli Du(trainee)+Teresa Smolarek
|    Myelodysplastic Syndrome (MDS) with  Multilineage Dysplasia||Disease||Xiaoli Du(trainee)+Teresa Smolarek
|
|
|FQR
|9/1/20
|PENDING
|PENDING
|
|
|FQR
|
|
|
|
Line 265: Line 296:
|    Myelodysplastic  Syndrome (MDS) with Excess Blasts||Disease||Xiaoli Du(trainee)+Teresa Smolarek
|    Myelodysplastic  Syndrome (MDS) with Excess Blasts||Disease||Xiaoli Du(trainee)+Teresa Smolarek
|
|
|FQR
|9/1/20
|PENDING
|PENDING
|
|
|FQR
|
|
|
|
Line 273: Line 305:
|    Myelodysplastic  Syndrome (MDS) with Isolated del(5q)||Disease||Xiaolin Hu(trainee)+Teresa Smolarek
|    Myelodysplastic  Syndrome (MDS) with Isolated del(5q)||Disease||Xiaolin Hu(trainee)+Teresa Smolarek
|
|
|FQR
|
|Complete
|Complete
|
|
|FQR
|
|
|
|
|-
|-
|    Myelodysplastic  Syndrome (MDS), Unclassifiable||Disease||Xiaolin Hu(trainee)+Teresa Smolarek
|    Myelodysplastic  Syndrome (MDS), Unclassifiable||Disease||Xiaolin Hu(trainee)+Teresa Smolarek
|
|
|complete
|
|
|FQR
|FQR
|PENDING
|
|
|
|
|
Line 289: Line 323:
|    Refractory Cytopenia  of Childhood||Disease||Xiaoli Du(trainee)+Teresa Smolarek
|    Refractory Cytopenia  of Childhood||Disease||Xiaoli Du(trainee)+Teresa Smolarek
|
|
|FQR
|9/1/20
|PENDING
|PENDING
|
|
|FQR
|
|
|
|
|-
|-
| || ||
| || ||
| ||
|
|
|
|
|
| ||
|
|
|
|
Line 304: Line 340:
|'''''Acute Myeloid Leukemia (AML) and Related Precursor Neoplasms'''''||'''''Overview'''''||Daynna Wolff+Daniel Butler (Path Resident)
|'''''Acute Myeloid Leukemia (AML) and Related Precursor Neoplasms'''''||'''''Overview'''''||Daynna Wolff+Daniel Butler (Path Resident)
|
|
|Jennelle Hodge (JH)/ Malini Sathanoori (MS)
|
|Complete
|Complete
|
|
|
|Jennelle Hodge (JH)/ Malini Sathanoori (MS)
|04/26/2021 -MS (re-review)
|
|
|-
|-
|'''''Myeloid Neoplasms with Germline Predisposition'''''||'''''Overview'''''||Ying  Zou
|'''''Myeloid Neoplasms with Germline Predisposition'''''||'''''Overview'''''||Ying  Zou
| ||JH / MS
|Complete
|
|
|
|
|Complete
| ||JH / MS
|03/01/2021-MS (re-review)
|
|
|-
|-
|    Acute Myeloid  Leukaemia with Germline CEBPA Mutation||Disease||Daynna Wolff+Matthew Kilpatrick (Path Resident)
|    Acute Myeloid  Leukaemia with Germline CEBPA Mutation||Disease||Daynna Wolff+Matthew Kilpatrick (Path Resident)
| ||JH / MS
|PENDING
|
|
|
|
|PENDING
| ||JH / MS
|04/26/2021 -MS (re-review)
|
|
|-
|-
|    Myeloid Neoplasms with Germline DDX41  Mutation||Disease||Fei Yang
|    Myeloid Neoplasms with Germline DDX41  Mutation||Disease||Fei Yang
| ||JH / MS
|PENDING
|
|
|
|
|Complete
| ||JH / MS
|03/01/2021-MS
|
|
|-
|-
|    Myeloid Neoplasms with Germline RUNX1  Mutation||Disease||Malini Sathanoori
|    Myeloid Neoplasms with Germline RUNX1  Mutation||Disease||Malini Sathanoori
| ||JH / MS
|PENDING
|
|
|
|Complete
|02/03/2021||JH / MS
|
|
|
|
|-
|-
|    Myeloid Neoplasms with Germline ANKRD26  Mutation||Disease||Fei Yang
|    Myeloid Neoplasms with Germline ANKRD26  Mutation||Disease||Fei Yang
| ||JH / MS
|PENDING
|
|
|
|
|Complete
| ||JH / MS
|03/02/2021-MS
|
|
|-
|-
|    Myeloid Neoplasms with Germline ETV6  Mutation||Disease||Ying Zou
|    Myeloid Neoplasms with Germline ETV6  Mutation||Disease||Ying Zou
| ||JH / MS
|Complete
|
|
|
|
|Complete
| ||JH / MS
|03/02/2021-MS (re-review)
|
|
|-
|-
|    Myeloid Neoplasms with Germline GATA2  Mutation||Disease||Daynna Wolff+ Alexandria Avery (Path Resident)
|    Myeloid Neoplasms with Germline GATA2  Mutation||Disease||Daynna Wolff+ Alexandria Avery (Path Resident)
| ||JH / MS
|Complete
|
|
|
|
|Complete
| ||JH / MS
|04/26/2021 -MS (re-review)
|
|
|-
|-
|'''''Acute Myeloid Leukemia (AML) with Recurrent Genetic  Abnormalities'''''||'''''Overview'''''||Daynna Wolff+ Dan Wang (trainee)
|'''''Acute Myeloid Leukemia (AML) with Recurrent Genetic  Abnormalities'''''||'''''Overview'''''||Daynna Wolff+ Dan Wang (trainee)
|
|
|JH / MS
|
|Complete
|Complete
|
|
|
|JH / MS
|03/01/2021-MS (re-review)
|
|
|-
|-
|    Acute Myeloid  Leukemia (AML) with t(8;21)(q22;q22.1); RUNX1-RUNX1T1||Disease||Christine Bryke
|    Acute Myeloid  Leukemia (AML) with t(8;21)(q22;q22.1); RUNX1-RUNX1T1||Disease||Christine Bryke
| ||JH / MS
|Complete
|
|
|
|
|Complete
| ||JH / MS
|04/26/2021-MS (re-review)
|
|
|-
|-
|    Acute Myeloid Leukemia with  inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11||Disease||Christine Bryke
|    Acute Myeloid Leukemia with  inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11||Disease||Christine Bryke
| ||JH / MS
|Complete
|
|
|
|
|Complete
| ||JH / MS
|03/01/2021-MS (re-review)
|
|
|-
|-
|    Acute Promyelocytic Leukemia (APL) with  PML-RARA||Disease||Shashi Shetty
|    Acute Promyelocytic Leukemia (APL) with  PML-RARA||Disease||Shashi Shetty
| ||JH / MS
|Complete
|
|
|
|
|Complete
| ||JH / MS
|03/01/2021-MS (re-review)
|
|
|-
|-
|    Acute Myeloid Leukemia (AML) with  t(9;11)(p21.3;q23.3); KMT2A-MLLT3||Disease||Shashi Shetty
|    Acute Myeloid Leukemia (AML) with  t(9;11)(p21.3;q23.3); KMT2A-MLLT3||Disease||Shashi Shetty
| ||JH / MS
|Complete
|
|
|
|
|Complete
| ||JH / MS
|03/01/2021-MS (re-review)
|
|
|-
|-
|    Acute Myeloid Leukemia (AML) with  t(6;9)(p23;q34.1); DEK-NUP214||Disease||Jennelle Hodge
|    Acute Myeloid Leukemia (AML) with  t(6;9)(p23;q34.1); DEK-NUP214||Disease||Jennelle Hodge
|
|
|Complete
| ||JH / MS
| ||JH / MS
|Complete
|02/24/2021-MS (re-review)
|
|
|-
|    Acute Myeloid Leukemia (AML) with  inv(3)(q21.3q26.2) or t(3;3)(q21.3;q26.2);GATA2, MECOM||Disease||Gordana Raca
|
|
|
|
|-
|Complete
|    Acute Myeloid Leukemia (AML) with  inv(3)(q21.3q26.2) or t(3;3)(q21.3;q26.2);GATA2, MECOM||Disease||Gordana Raca
| ||JH / MS
| ||JH / MS
|Complete
|
|
|
|Need permission for figure?  Update WHO?
|Need permission for figure?  Update WHO?
|-
|-
|    Acute Myeloid Leukemia (AML)  Megakaryoblastic with t(1;22)(p13.3;q13.1);RBM15-MKL1||Disease||Jennelle Hodge
|    Acute Myeloid Leukemia (AML)  Megakaryoblastic with t(1;22)(p13.3;q13.1);RBM15-MKL1||Disease||Jennelle Hodge
|
|
|Complete
| ||JH / MS
| ||JH / MS
|Complete
|
|
|
|
|
|-
|-
|    Acute Myeloid Leukemia (AML) with  BCR-ABL1||Disease||Kay Weng Choy + Greg Conboy (Monash Health)
|    Acute Myeloid Leukemia (AML) with  BCR-ABL1||Disease||Kay Weng Choy + Greg Conboy (Monash Health)
|
|
|Complete
| ||JH / MS
| ||JH / MS
|Complete
|
|
|
|
|
|-
|-
|    Acute Myeloid Leukemia (AML) with  Mutated NPM1||Disease||Xinjie Xu+Kay Weng Choy + Greg Conboy (Monash Health)
|    Acute Myeloid Leukemia (AML) with  Mutated NPM1||Disease||Xinjie Xu+Kay Weng Choy + Greg Conboy (Monash Health)
|
|
|Complete
| ||JH / MS
| ||JH / MS
|Complete
|
|
|
|Add WHO reference
|Add WHO reference
|-
|-
|    Acute Myeloid Leukemia (AML) with  Biallelic Mutations of CEBPA||Disease||Paul deFazio, MSc + Greg  Conboy (Monash Health)
|    Acute Myeloid Leukemia (AML) with  Biallelic Mutations of CEBPA||Disease||Paul deFazio, MSc + Greg  Conboy (Monash Health)
|
|
|Complete
| ||JH / MS
| ||JH / MS
|Complete
|
|
|
|
|
|-
|-
|    Acute Myeloid Leukemia (AML) with  Mutated RUNX1||Disease||Daynna Wolff+Iris Martin (Path Resident)
|    Acute Myeloid Leukemia (AML) with  Mutated RUNX1||Disease||Daynna Wolff+Iris Martin (Path Resident)
| ||JH / MS
|Complete
|
|
|
|Complete
| ||JH / MS
|
|
|
|
|-
|-
|Acute Myeloid Leukemia (AML) with Myelodysplasia-Related Changes||Disease||Fei Yang
|Acute Myeloid Leukemia (AML) with Myelodysplasia-Related Changes||Disease||Fei Yang
|
|
|Complete
| ||JH / MS
| ||JH / MS
|Complete
|
|
|
|
|
|-
|-
|Therapy-Related Myeloid Neoplasms||Disease||Shashi Shetty + Shawn A. Silver (resident)
|Therapy-Related Myeloid Neoplasms||Disease||Shashi Shetty + Shawn A. Silver (resident)
|
|
|Complete
| ||JH / MS
| ||JH / MS
|Complete
|
|
|
|Check reference format
|Check reference format
|-
|-
|''Acute Myeloid Leukemia (AML), Not Otherwise Specified''||'''''Overview'''''||Anwar Iqbal
|''Acute Myeloid Leukemia (AML), Not Otherwise Specified''||'''''Overview'''''||Anwar Iqbal
|
|
|Complete
| ||JH / MS
| ||JH / MS
|Complete
|
|
|
|
|
|-
|-
|    Acute Myeloid  Leukemia (AML) with Minimal Differentiation||Disease||Fabiola Quintero-Rivera and Celeste Eno (fellow)
|    Acute Myeloid  Leukemia (AML) with Minimal Differentiation||Disease||Fabiola Quintero-Rivera and Celeste Eno (fellow)
|
|
|Complete
| ||JH / MS
| ||JH / MS
|Complete
|
|
|
|
|
|-
|-
|   Acute Myeloid Leukemia (AML) without Maturation||Disease||Jennelle Hodge
|   Acute Myeloid Leukemia (AML) without Maturation||Disease||Jennelle Hodge
|
|
|Complete
| ||JH / MS
| ||JH / MS
|Complete
|
|
|
|
|
|-
|-
|    Acute Myeloid Leukemia (AML) with Maturation||Disease||Jennelle Hodge
|    Acute Myeloid Leukemia (AML) with Maturation||Disease||Jennelle Hodge
|
|
|Complete
| ||JH / MS
| ||JH / MS
|Complete
|
|
|
|
|
|-
|-
|    Acute Myelomonocytic Leukemia||Disease||Fei Yang
|    Acute Myelomonocytic Leukemia||Disease||Fei Yang
|
|
|Complete
| ||JH / MS
| ||JH / MS
|Complete
|
|
|
|
|
|-
|-
|    Acute Monoblastic and Monocytic Leukemia||Disease||Fei Yang
|    Acute Monoblastic and Monocytic Leukemia||Disease||Fei Yang
|
|
|Complete
| ||JH / MS
| ||JH / MS
|Complete
|
|
|
|
|
|-
|-
|    Pure Erythroid Leukemia||Disease||Ash  Yenamandra
|    Pure Erythroid Leukemia||Disease||Ash  Yenamandra
|
|
|Complete
| ||JH / MS
| ||JH / MS
|Complete
|
|
|
|
|
|-
|-
|    Acute Megakaryoblastic Leukemia (AMKL)||Disease||Fei Yang
|    Acute Megakaryoblastic Leukemia (AMKL)||Disease||Fei Yang
|
|
|Complete
| ||JH / MS
| ||JH / MS
|Complete
|
|
|
|
|
|-
|-
|    Acute Basophilic Leukemia||Disease||Ash Yenamandra
|    Acute Basophilic Leukemia||Disease||Ash Yenamandra
|
|
|Complete
| ||JH / MS
| ||JH / MS
|Complete
|
|
|
|
|
|-
|-
|    Acute Panmyelosis with Myelofibrosis||Disease||Ying Zou and Jialing Huang (MGP fellow)
|    Acute Panmyelosis with Myelofibrosis||Disease||Ying Zou and Jialing Huang (MGP fellow)
|
|
|Complete
| ||JH / MS
| ||JH / MS
|Complete
|
|
|
|
|
|-
|-
|Myeloid Sarcoma||Disease||Fabiola Quintero-Rivera
|Myeloid Sarcoma||Disease||Fabiola Quintero-Rivera
|
|
|Complete
| ||JH / MS
| ||JH / MS
|Complete
|
|
|
|
|
|-
|-
|'''''Myeloid Proliferations Associated with Down Syndrome'''''||'''''Overview'''''||Patty  Greipp
|'''''Myeloid Proliferations Associated with Down Syndrome'''''||'''''Overview'''''||Patty  Greipp
|
|
|Complete
| ||JH / MS
| ||JH / MS
|Complete
|
|
|
|Need permission for figure?
|Need permission for figure?
|-
|-
|    Transient Abnormal Myelopoiesis (TAM)  Associated with Down Syndrome||Disease||Linda Cooley
|    Transient Abnormal Myelopoiesis (TAM)  Associated with Down Syndrome||Disease||Linda Cooley
|
|
|Complete
| ||JH / MS
| ||JH / MS
|Complete
|
|
|
|
|
|-
|-
|    Myeloid Leukemia Associated with Down  Syndrome||Disease||Linda Cooley
|    Myeloid Leukemia Associated with Down  Syndrome||Disease||Linda Cooley
|
|
|Complete
| ||JH / MS
| ||JH / MS
|Complete
|
|
|
|
|
|-
|-
|Blastic Plasmacytoid Dendritic Cell Neoplasm||Disease||Daynna Wolff+Hao Liu (Path Resident)
|Blastic Plasmacytoid Dendritic Cell Neoplasm||Disease||Daynna Wolff+Hao Liu (Path Resident)
|
|
|Complete
| ||JH / MS
| ||JH / MS
|Complete
|
|
|
|
|
|-
|-
|'''''Acute Leukemias of Ambiguous Lineage'''''||'''''Overview'''''||Hui Chen/ Jennelle Hodge
|'''''Acute Leukemias of Ambiguous Lineage'''''||'''''Overview'''''||Hui Chen/ Jennelle Hodge
|
|
|Complete
| ||JH / MS
| ||JH / MS
|Complete
|
|
|
|
|
|-
|-
|    Acute  Undifferentiated Leukemia||Disease||Shashi Shetty + Amelia Nakanishi (resident)
|    Acute  Undifferentiated Leukemia||Disease||Shashi Shetty + Amelia Nakanishi (resident)
|
|
|Complete
| ||JH / MS
| ||JH / MS
|Complete
|
|
|
|Check reference format
|Check reference format
|-
|-
|    Mixed Phenotype Acute  Leukemia (MPAL) with t(9;22)(q34.1;q11.2); BCR-ABL1||Disease||Tracy Tucker
|    Mixed Phenotype Acute  Leukemia (MPAL) with t(9;22)(q34.1;q11.2); BCR-ABL1||Disease||Tracy Tucker
| ||JH / MS
|Complete
|
|
|
|Complete
| ||JH / MS
|
|
|
|
|-
|-
|    Mixed Phenotype Acute Leukemia (MPAL)  with t(v;11q23.3); KMT2A Rearranged||Disease||Tracy Tucker
|    Mixed Phenotype Acute Leukemia (MPAL)  with t(v;11q23.3); KMT2A Rearranged||Disease||Tracy Tucker
|
|
|Complete
| ||JH / MS
| ||JH / MS
|Complete
|
|
|
|
|
|-
|-
|    Mixed Phenotype Acute Leukemia (MPAL),  B/Myeloid, Not Otherwise Specified||Disease||Shashi Shetty + Priyatharsini Nirmalanantham (resident)
|    Mixed Phenotype Acute Leukemia (MPAL),  B/Myeloid, Not Otherwise Specified||Disease||Shashi Shetty + Priyatharsini Nirmalanantham (resident)
|
|
|Complete
| ||JH / MS
| ||JH / MS
|Complete
|
|
|
|
|Check reference format
|-
|-
|    Mixed Phenotype Acute Leukemia (MPAL),  T/Myeloid, Not Otherwise Specified||Disease||Fabiola Quintero-Rivera
|    Mixed Phenotype Acute Leukemia (MPAL),  T/Myeloid, Not Otherwise Specified||Disease||Fabiola Quintero-Rivera
|
|
|Complete
| ||JH / MS
| ||JH / MS
|Complete
|
|
|
|-
|    Mixed-Phenotype Acute Leukemia, Not  Otherwise Specified (NOS), Rare Types||Disease||Daynna Wolff+ Elicia Goodale (resident)
|
|
|
|
|-
|PENDING
|    ??Mixed-Phenotype Acute Leukaemia, Not  Otherwise Specified (NOS), Rare Types||Disease||
| ||JH / MS
| ||JH / MS
|??
|
|
|
|-
|    Acute Leukemias of Ambiguous Lineage,  Not Otherwise Specified (NOS)||Disease||Daynna Wolff+Madison Hannay or Elicia Goodale (residents)
|
|
|
|
|-
|PENDING
|    ??Acute Leukaemias of Ambiguous Lineage,  Not Otherwise Specified (NOS)||Disease||
| ||JH / MS
| ||JH / MS
|??
|
|
|
|
|
Line 623: Line 704:
|Kay Weng Choy + Greg Conboy (Monash Health)
|Kay Weng Choy + Greg Conboy (Monash Health)
|
|
|JH / MS
|
|Complete
|Complete
|
|
|JH / MS
|
|
|NON-WHO ENTITY
|NON-WHO ENTITY
Line 633: Line 715:
|Daynna Wolff+Jessica Snider (Path Resident)
|Daynna Wolff+Jessica Snider (Path Resident)
|
|
|JH / MS
|
|PENDING
|PENDING
|
|
|JH / MS
|
|
|NON-WHO ENTITY
|NON-WHO ENTITY
Line 643: Line 726:
|Daynna Wolff+ Paige Woodham (Path Resident)
|Daynna Wolff+ Paige Woodham (Path Resident)
|
|
|JH / MS
|
|PENDING
|PENDING
|
|
|JH / MS
|
|
|NON-WHO ENTITY
|NON-WHO ENTITY
|-
|-
| || ||
| || ||
| ||
|
|
|
|
|
| ||
|
|
|
|
|-
|-
|'''''Precursor Lymphoid Neoplasms'''''||'''''Overview'''''||
|'''''Precursor Lymphoid Neoplasms'''''||'''''Overview'''''||
| ||Yassmine Akkari (YA)
|
|
|
|
|
| ||Yassmine Akkari (YA)
|
|
|
|
|-
|-
|'''''B-Lymphoblastic Leukemia/Lymphoma with Recurrent Genetic  Abnormalities'''''||'''''Overview'''''||
|'''''B-Lymphoblastic Leukemia/Lymphoma with Recurrent Genetic  Abnormalities'''''||'''''Overview'''''||
| ||YA
|
|
|
|
|
| ||YA
|
|
|
|
|-
|-
|    B-Lymphoblastic  Leukemia/Lymphoma with t(9;22)(q34.1;q11.2); BCR-ABL1    ||Disease||
|    B-Lymphoblastic  Leukemia/Lymphoma with t(9;22)(q34.1;q11.2); BCR-ABL1    ||Disease||Afia Hasnain + Yassmine Akkari
| ||YA
|
|
|
|
|PENDING
| ||YA
|
|
|
|
Line 679: Line 767:
|    B-Lymphoblastic Leukemia/Lymphoma with  t(v;11q23.3); KMT2A-Rearranged||Disease||Yassmine Akkari+Nicolas Millan (trainee)
|    B-Lymphoblastic Leukemia/Lymphoma with  t(v;11q23.3); KMT2A-Rearranged||Disease||Yassmine Akkari+Nicolas Millan (trainee)
|
|
|YA
|
|PENDING
|PENDING
|
|
|YA
|
|
|
|
|-
|-
|    B-Lymphoblastic Leukemia/Lymphoma with  t(12;21)(p13.2;q22.1); ETV6-RUNX1||Disease||
|    B-Lymphoblastic Leukemia/Lymphoma with  t(12;21)(p13.2;q22.1); ETV6-RUNX1||Disease||Marilena Melas + Yassmine Akkari
| ||YA
|
|
|
|
|PENDING
| ||YA
|
|
|
|
|-
|-
|    B-Lymphoblastic Leukemia/Lymphoma with  Hyperdiploidy||Disease||
|    B-Lymphoblastic Leukemia/Lymphoma with  Hyperdiploidy||Disease||Afia Hasnain + Yassmine Akkari
| ||YA
|
|
|
|
|PENDING
| ||YA
|
|
|
|
Line 703: Line 794:
Lisa Smith + Yassmine Akkari
Lisa Smith + Yassmine Akkari
|
|
|YA
|
|Complete
|Complete
|
|
|YA
|
|
|
|
|-
|-
|    B-Lymphoblastic Leukemia/Lymphoma with  t(5;14)(q31.1;q32.1); IGH/IL3||Disease||
|    B-Lymphoblastic Leukemia/Lymphoma with  t(5;14)(q31.1;q32.1); IGH/IL3||Disease||Binu Porath + Linda Cooley
| ||YA
|
|
|
|
|PENDING
| ||YA
|
|
|
|
|-
|-
|    B-Lymphoblastic Leukemia/Lymphoma with  t(1;19)(q23;p13.3); TCF3-PBX1||Disease||
|    B-Lymphoblastic Leukemia/Lymphoma with  t(1;19)(q23;p13.3); TCF3-PBX1||Disease||Binu Porath + Linda Cooley
| ||YA
|
|
|
|
|PENDING
| ||YA
|
|
|
|
Line 725: Line 819:
|    B-Lymphoblastic Leukemia/Lymphoma,  BCR-ABL1-Like||Disease||Mark G. Evans + Fabiola Quintero-Rivera
|    B-Lymphoblastic Leukemia/Lymphoma,  BCR-ABL1-Like||Disease||Mark G. Evans + Fabiola Quintero-Rivera
|
|
|YA
|
|Complete
|Complete
|
|
|YA
|
|
|
|
|-
|-
|    B-Lymphoblastic Leukemia/Lymphoma with  iAMP21||Disease||
|    B-Lymphoblastic Leukemia/Lymphoma with  iAMP21||Disease||Holli Drendel
| ||YA
|
|
|
|
|PENDING
| ||YA
|
|
|
|
|-
|-
|    B-Lymphoblastic Leukemia/Lymphoma, Not  Otherwise Specified||Disease||
|    B-Lymphoblastic Leukemia/Lymphoma, Not  Otherwise Specified||Disease||Holli Drendel
| ||YA
|
|
|
|
|PENDING
| ||YA
|
|
|
|
|-
|-
|'''''T-Lymphoblastic Leukemia/Lymphoma'''''||'''''Overview'''''||
|B-Lymphoblastic Leukemia/Lymphoma with t(4;14)(q35.2;q32); IGH/DUX4
| ||YA
|Disease
|Diana Rush
|
|
|
|
|PENDING
|
|
|YA
|
|
|NON-WHO ENTITY
|-
|-
|Early T-Cell Precursor Lymphoblastic Leukemia||Disease||
|B-Lymphoblastic Leukemia/Lymphoma with dic(9;12)(p13;p13); PAX5/ETV6
| ||YA
|Disease
|Celeste Eno
|
|
|
|
|PENDING
|
|
|YA
|
|
|NON-WHO ENTITY
|-
|-
|NK-Lymphoblastic Leukemia/Lymphoma||Disease||
|B-Lymphoblastic Leukemia/Lymphoma with ZNF384 Rearrangements
| ||YA
|Disease
|Marilena Melas
|
|
|
|
|PENDING
|
|
|YA
|
|
|NON-WHO ENTITY
|-
|-
|B-Lymphoblastic Leukemia/Lymphoma with ZNF384 Rearrangements
|B-Lymphoblastic Leukemia/Lymphoma with IKZF1 Deletions
|Disease
|Disease
|Helene Bruyere
|Chenkai Ma
|
|
|
|YA
|PENDING
|PENDING
|
|
|YA
|
|
|NON-WHO ENTITY
|NON-WHO ENTITY
|-
|-
| || ||
|B-Lymphoblastic Leukemia/Lymphoma with TCF3 Rearrangements - Excluding t(1;19) and t(12;19)
| ||
|Disease
|Celeste Eno
|
|
|
|
|PENDING
|
|
|YA
|
|
|NON-WHO ENTITY
|-
|-
|'''''Mature B-Cell Neoplasms'''''||'''''Overview'''''||
|B-Lymphoblastic Leukemia/Lymphoma with dic(9;20)(p13;q11)
| ||Snehal Patel (SP)
|Disease
|Alaa Koleilat
|
|
|
|
|PENDING
|
|
|YA
|
|
|NON-WHO ENTITY
|-
|-
|Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma||Disease||Honey Reddi
|'''''T-Lymphoblastic Leukemia/Lymphoma'''''||'''''Overview'''''||Fei Yang
|
|
|
|SP
|PENDING
|PENDING
| ||YA
|
|
|
|
|-
|Early T-Cell Precursor Lymphoblastic Leukemia||Disease||Fei Yang
|
|
|-
|       Monoclonal B-cell  Lymphocytosis||Disease||Honey Reddi
|
|
|SP
|PENDING
|PENDING
| ||YA
|
|
|
|
|-
|NK-Lymphoblastic Leukemia/Lymphoma||Disease||Fei Yang
|
|
|-
|B-cell Prolymphocytic Leukemia||Disease||Honey Reddi
|
|
|SP
|PENDING
|PENDING
|
| ||YA
|
|
|
|
|-
|-
|Splenic Marginal Zone Lymphoma||Disease||Snehal Patel
| || ||
|
|
|SP
|Complete
|
|
|
|
|Malini to review
| ||
|-
|Hairy Cell Leukemia||Disease||Snehal Patel
|
|SP
|Complete
|
|
|
|
|Malini to review
|-
|-
|'''''Splenic B-cell Lymphoma/Leukemia, Unclassifiable'''''||'''''Overview'''''||Snehal Patel
|'''''Mature B-Cell Neoplasms'''''||'''''Overview'''''||
|
|
|SP
|Complete
|
|
|
|
|Malini to review
| ||Snehal Patel (SP)
|
|
|-
|-
|    Splenic Diffuse Red  Pulp Small B-cell Lymphoma||Disease||Snehal Patel
|Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma||Disease||
|
|
|SP
|Complete
|
|
|
|
|Malini to review
|-
|    Hairy Cell Leukemia  Variant||Disease||Snehal Patel
|
|
|SP
|SP
|Complete
|
|
|
|
|Malini to review
|-
|-
|Lymphoplasmacytic Lymphoma||Disease||Honey Reddi
|       Monoclonal B-cell  Lymphocytosis||Disease||
|
|SP
|PENDING
|
|
|
|
|
|
|-
|   Waldenstrom  Macroglobulinemia||Disease||Honey Reddi
|
|
|SP
|SP
|PENDING
|
|
|
|
|
|-
|-
|IgM Monoclonal Gammopathy of Undetermined Significance||Disease||
|B-cell Prolymphocytic Leukemia||Disease||
| ||SP
|
|
|
|
|
|
|
|
|-
|SP
|'''''Heavy Chain Diseases'''''||'''''Overview'''''||
| ||SP
|
|
|
|
|-
|Splenic Marginal Zone Lymphoma||Disease||Snehal Patel
|
|
|
|
|-
|Complete
|    Mu Heavy Chain  Disease||Disease||
| ||SP
|
|
|
|SP
|
|
|
|
|-
|-
|   Gamma Heavy Chain  Disease||Disease||
|Hairy Cell Leukemia||Disease||Snehal Patel
| ||SP
|
|
|
|
|Complete
|
|SP
|
|
|
|
|-
|-
|    Alpha Heavy Chain  Disease||Disease||
|'''''Splenic B-cell Lymphoma/Leukemia, Unclassifiable'''''||'''''Overview'''''||Snehal Patel
| ||SP
|
|
|
|
|Complete
|
|SP
|
|
|
|
|-
|-
|Plasma Cell Neoplasms||'''''Overview'''''||Zhenya Tang
|    Splenic Diffuse Red  Pulp Small B-cell Lymphoma||Disease||Snehal Patel
|
|
|Complete
|
|
|SP
|SP
|PENDING
|
|
|
|-
|    Hairy Cell Leukemia  Variant||Disease||Snehal Patel
|
|
|
|
|-
|Complete
|   Non-IgM Monoclonal  Gammopathy of Undetermined Significance||Disease||Zhenya Tang
|
|
|SP
|SP
|PENDING
|
|
|
|
|
|-
|-
|    Plasma Cell Myeloma||Disease||Zhenya Tang/Huang Mo (trainee)
|Lymphoplasmacytic Lymphoma||Disease||
|
|SP
|PENDING
|
|
|
|
|
|
|-
|    Plasma Cell Myeloma  Variants||Disease||Zhenya Tang
|
|
|SP
|SP
|PENDING
|
|
|
|
|-
|   Waldenstrom  Macroglobulinemia||Disease||
|
|
|-
|    Plasmacytoma||Disease||Zhenya Tang
|
|
|SP
|PENDING
|
|
|
|SP
|
|
|
|
|-
|-
|'''''    Monoclonal Immunoglobulin Deposition Diseases'''''||'''''Overview'''''||
|IgM Monoclonal Gammopathy of Undetermined Significance||Disease||
| ||SP
|
|
|
|
|
| ||SP
|
|
|
|
|-
|-
|           Primary  Amyloidosis||Disease||
|'''''Heavy Chain Diseases'''''||'''''Overview'''''||
| ||SP
|
|
|
|
|
| ||SP
|
|
|
|
|-
|-
|           Light Chain  and Heavy Chain Deposition Disease||Disease||
|    Mu Heavy Chain  Disease||Disease||
| ||SP
|
|
|
|
|
| ||SP
|
|
|
|
|-
|-
|'''''Plasma Cell Neoplasms with Associated Paraneoplastic Syndrome'''''||'''''Overview'''''||
|   Gamma Heavy Chain  Disease||Disease||Manisha Sutariya
| ||SP
|
|
|
|
|Complete
|5/26/2021||SP
|
|
|
|
|-
|-
|         POEMS Syndrome||Disease||
|    Alpha Heavy Chain  Disease||Disease||
| ||SP
|
|
|
|
|
|
|
|-
|         TEMPI Syndrome||Disease||
| ||SP
| ||SP
|
|
|
|
|-
|Plasma Cell Neoplasms||'''''Overview'''''||Zhenya Tang
|
|
|
|
|-
|PENDING
|Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid  Tissue (MALT Lymphoma)||Disease||Zhenya Tang & Trainee
|
|
|SP
|SP
|PENDING
|
|
|
|
|
|-
|-
|Nodal Marginal Zone Lymphoma||Disease||
|   Non-IgM Monoclonal  Gammopathy of Undetermined Significance||Disease||Zhenya Tang
| ||SP
|
|
|
|
|PENDING
|
|SP
|
|
|
|
|-
|-
|    Paediatric Nodal  Marginal Zone Lymphoma||Disease||Ruthann Pfau, Kathleen Schieffer (trainee)
|    Plasma Cell Myeloma||Disease||Zhenya Tang/Huang Mo (trainee)
|
|
|
|SP
|PENDING
|PENDING
|
|
|SP
|
|
|
|
|-
|-
|Follicular Lymphoma||Disease||Ruthann Pfau
|    Plasma Cell Myeloma Variants||Disease||Fariborz Rashid-Kolvear
|
|
|
|SP
|PENDING
|PENDING
|
|
|SP
|
|
|
|
|-
|-
|    Testicular Follicular  Lymphoma||Disease||Ruthann Pfau
|    Plasmacytoma||Disease||Zhenya Tang
|
|
|
|SP
|PENDING
|PENDING
|
|
|SP
|
|
|
|
|-
|-
|    In Situ Follicular Neoplasia||Disease||Ruthann Pfau
|'''''    Monoclonal Immunoglobulin Deposition Diseases'''''||'''''Overview'''''||
|
|
|
|SP
|PENDING
|
|
| ||SP
|
|
|
|
|-
|-
|    Duodenal-Type Follicular Lymphoma||Disease||Ruthann Pfau
|           Primary Amyloidosis||Disease||
|
|
|
|SP
|PENDING
|
|
| ||SP
|
|
|
|
|-
|-
|Paediatric-Type Follicular Lymphoma||Disease||Ruthann Pfau, Kathleen Schieffer (trainee)
|           Light Chain  and Heavy Chain Deposition Disease||Disease||
|
|
|SP
|PENDING
|
|
|
| ||SP
|
|
|
|
|-
|-
|Large B-cell Lymphoma with IRF4 Rearrangement||Disease||
|'''''Plasma Cell Neoplasms with Associated Paraneoplastic Syndrome'''''||'''''Overview'''''||
| ||SP
|
|
|
|
|
| ||SP
|
|
|
|
|-
|-
|Primary Cutaneous Follicle Centre Lymphoma||Disease||
|         POEMS Syndrome||Disease||
| ||SP
|
|
|
|
|
| ||SP
|
|
|
|
|-
|-
|Mantle Cell Lymphoma||Disease||Mahsa Khanlari
|         TEMPI Syndrome||Disease||
|
|
|
|SP
|PENDING - due 8/15/20
|
|
| ||SP
|
|
|
|
|-
|-
|    Leukemic Non-Nodal Mantle Cell Lymphoma||Disease||Mahsa Khanlari
|Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue (MALT Lymphoma)||Disease||Whayoung Lee, trainee)/Fabiola Quintero-Rivera
|3/9/21
|
|PENDING
|
|
|SP
|SP
|PENDING - due 8/31/20
|
|
|
|
|
|-
|-
|    In Situ Mantle Cell  Neoplasia||Disease||Mahsa Khanlari
|Nodal Marginal Zone Lymphoma||Disease||Shivani Golem
|
|
|SP
|PENDING - due 8/15/20
|
|
|Complete
|5/28/2021||SP
|
|
|
|
|-
|-
| || ||
|    Paediatric Nodal  Marginal Zone Lymphoma||Disease||Ruthann Pfau, Kathleen Schieffer (trainee)
| ||
|
|
|
|
|Complete
|11/11/2020
|SP
|
|
|
|
|-
|-
|Diffuse Large B-cell Lymphoma, Not Otherwise Specified||Disease||Ashwini Yenamandra
|Follicular Lymphoma||Disease||Ruthann Pfau
|
|
|
|Greg Corboy (GC)
|PENDING
|PENDING
|
|
|SP
|
|
|
|
|-
|-
|T-cell/Histiocyte-Rich Large B-cell Lymphoma||Disease||
|    Testicular Follicular  Lymphoma||Disease||Ruthann Pfau
| ||GC
|
|
|
|
|PENDING
|
|SP
|
|
|
|
|-
|-
|Primary Diffuse Large B-cell Lymphoma of the CNS||Disease||
|    In Situ Follicular  Neoplasia||Disease||Ruthann Pfau
| ||GC
|
|
|
|PENDING
|
|
|SP
|
|
|
|
|-
|-
|Primary Cutaneous Diffuse Large B-cell Lymphoma, Leg Type||Disease||
|    Duodenal-Type  Follicular Lymphoma||Disease||Ruthann Pfau
| ||GC
|
|
|
|PENDING
|
|
|SP
|
|
|
|
|-
|-
|EBV-Positive Diffuse Large B-cell Lymphoma, Not Otherwise  Specified (NOS)||Disease||
|Paediatric-Type Follicular Lymphoma||Disease||Ruthann Pfau, Kathleen Schieffer (trainee)
| ||GC
|
|
|
|
|Complete
|8/16/2020
|SP
|
|
|
|
|-
|-
|EBV-Positive Mucocutaneous Ulcer||Disease||
|Large B-cell Lymphoma with IRF4 Rearrangement||Disease||Afia Hasnaid
| ||GC
|
|
|
|9/30/20
|Complete
|5/26/2021||SP
|
|
|
|
|-
|-
|Diffuse Large B-cell Lymphoma Associated with Chronic  Inflammation||Disease||
|Primary Cutaneous Follicle Centre Lymphoma||Disease||Shivani Golem
| ||GC
|
|
|
|
|PENDING
| ||SP
|
|
|
|
|-
|-
|    Fibrin-Associated  Diffuse Large B-cell Lymphoma||Disease||
|Mantle Cell Lymphoma||Disease||Mahsa Khanlari
| ||GC
|
|
|8/15/20
|PENDING
|
|
|SP
|
|
|
|
|-
|-
|Lymphomatoid Granulomatosis||Disease||
|    Leukemic Non-Nodal  Mantle Cell Lymphoma||Disease||
| ||GC
|
|
|
|
|
|
|SP
|
|
|
|
|-
|-
|Primary Mediastinal (Thymic) Large B-cell Lymphoma||Disease||
|    In Situ Mantle Cell  Neoplasia||Disease||
| ||GC
|
|
|
|
|
|
|SP
|
|
|
|
|-
|-
|Intravascular Large B-cell Lymphoma||Disease||
| || ||
| ||GC
|
|
|
|
|
| ||
|
|
|
|
|-
|-
|ALK-Positive Large B-cell Lymphoma||Disease||
|Diffuse Large B-cell Lymphoma, Not Otherwise Specified||Disease||Ashwini Yenamandra
| ||GC
|
|
|
|PENDING
|
|
|Greg Corboy (GC)
|
|
|
|
|-
|-
|Plasmablastic Lymphoma||Disease||Mark Evans (trainee), Fabiola Quintero-Rivera
|T-cell/Histiocyte-Rich Large B-cell Lymphoma||Disease||
| ||GC
|Complete
|
|
|
|
|
|
|-
|Primary Effusion Lymphoma||Disease||
| ||GC
| ||GC
|
|
|
|-
|Primary Diffuse Large B-cell Lymphoma of the CNS||Disease||
|
|
|
|
|
|
|-
|'''''HHV8-Associated Lymphoproliferative Disorders'''''||'''''Overview'''''||
| ||GC
| ||GC
|
|
|
|
|
|
|-
|-
|   Multicentric Castleman  Disease||Disease||
|Primary Cutaneous Diffuse Large B-cell Lymphoma, Leg Type||Disease||
| ||GC
|
|
|
|
|
| ||GC
|
|
|
|
|-
|-
|   HHV8-Positive Diffuse Large B-cell Lymphoma, Not Otherwise Specified (NOS)||Disease||
|EBV-Positive Diffuse Large B-cell Lymphoma, Not Otherwise Specified (NOS)||Disease||
| ||GC
|
|
|
|
|
| ||GC
|
|
|
|
|-
|-
|   HHV8-Positive Germinotropic Lymphoproliferative Disorder||Disease||
|EBV-Positive Mucocutaneous Ulcer||Disease||
| ||GC
|
|
|
|
|
| ||GC
|
|
|
|
|-
|-
|Burkitt Lymphoma||Disease||
|Diffuse Large B-cell Lymphoma Associated with Chronic  Inflammation||Disease||
| ||GC
|
|
|
|
|
| ||GC
|
|
|
|
|-
|-
|Burkitt-Like Lymphoma with 11q Aberration||Disease||
|    Fibrin-Associated  Diffuse Large B-cell Lymphoma||Disease||
| ||GC
|
|
|
|
|
| ||GC
|
|
|
|
|-
|-
|'''''High-Grade B-cell Lymphoma'''''||'''''Overview'''''||
|Lymphomatoid Granulomatosis||Disease||
| ||GC
|
|
|
|
|
| ||GC
|
|
|
|
|-
|-
|    High-Grade B-cell Lymphoma with MYC and BCL2 and/or BCL6 Rearrangements||Disease||
|Primary Mediastinal (Thymic) Large B-cell Lymphoma||Disease||
| ||GC
|
|
|
|
|
| ||GC
|
|
|
|
|-
|-
|    High-Grade B-cell Lymphoma, Not Otherwise Specified (NOS)||Disease||
|Intravascular Large B-cell Lymphoma||Disease||
| ||GC
|
|
|
|
|
| ||GC
|
|
|
|
|-
|-
|B-cell Lymphoma, Unclassifiable, with Features Intermediate  Between Diffuse Large B-cell Lymphoma and Classic Hodgkin Lymphoma||Disease||
|ALK-Positive Large B-cell Lymphoma||Disease||
| ||GC
|
|
|
|
|
| ||GC
|
|
|
|
|-
|-
| || ||
|Plasmablastic Lymphoma||Disease||Mark Evans (trainee), Fabiola Quintero-Rivera
| ||
|
|
|
|
|Complete
| ||GC
|
|
|
|
|-
|-
|'''''Mature T- and NK-cell Neoplasms'''''||'''''Overview'''''||
|Primary Effusion Lymphoma||Disease||
| ||Snehal Patel (SP)
|
|
|
|
|
| ||GC
|
|
|
|
|-
|-
|T-cell Prolymphocytic Leukemia||Disease||Michelle Don
|'''''HHV8-Associated Lymphoproliferative Disorders'''''||'''''Overview'''''||
| ||SP
|
|PENDING
|
|
|
| ||GC
|
|
|
|
|-
|-
|T-cell Large Granular Lymphocytic Leukemia||Disease||Michelle Don
|   Multicentric Castleman  Disease||Disease||
| ||SP
|PENDING
|
|
|
|
|
|
|-
| ||GC
|Chronic Lymphoproliferative Disorder of NK Cells||Disease||Michelle Don
| ||SP
|PENDING
|
|
|
|
|-
|   HHV8-Positive Diffuse  Large B-cell Lymphoma, Not Otherwise Specified (NOS)||Disease||
|
|
|-
|Aggressive NK-cell Leukemia||Disease||
| ||SP
|
|
|
|
| ||GC
|
|
|
|
|-
|-
|'''''EBV-Positive T-cell and NK-cell Lymphoproliferative Diseases of  Childhood'''''||'''''Overview'''''||
|   HHV8-Positive Germinotropic Lymphoproliferative Disorder||Disease||
| ||SP
|
|
|
|
|
| ||GC
|
|
|
|
|-
|-
|  Systemic EBV-Positive  T-cell Lymphoma of Childhood||Disease||
|Burkitt Lymphoma||Disease||Becky Leung (trainee), Greg Corboy
| ||SP
|3/11/21
|
|
|PENDING
| ||GC
|
|
|
|
|-
|Burkitt-Like Lymphoma with 11q Aberration||Disease||
|
|
|-
|   Chronic Active EBV  Infection of T- and NK-cell Type, Systemic Form||Disease||
| ||SP
|
|
|
|
| ||GC
|
|
|
|
|-
|-
|    Hydroa  Vacciniforme-Like Lymphoproliferative Disorder||Disease||
|'''''High-Grade B-cell Lymphoma'''''||'''''Overview'''''||
| ||SP
|
|
|
|
|
| ||GC
|
|
|
|
|-
|-
|    Severe Mosquito Bite Allergy||Disease||
|    High-Grade B-cell Lymphoma with MYC and BCL2 and/or BCL6 Rearrangements||Disease||
| ||SP
|
|
|
|
|
| ||GC
|
|
|
|
|-
|-
|Adult T-cell Leukemia/Lymphoma||Disease||
|    High-Grade B-cell Lymphoma, Not Otherwise Specified (NOS)||Disease||
| ||SP
|
|
|
|
|
| ||GC
|
|
|
|
|-
|-
|Extranodal NK/T-cell Lymphoma, Nasal Type||Disease||
|B-cell Lymphoma, Unclassifiable, with Features Intermediate  Between Diffuse Large B-cell Lymphoma and Classic Hodgkin Lymphoma||Disease||
| ||SP
|
|
|
|
|
| ||GC
|
|
|
|
|-
|-
|'''''Intestinal T-cell Lymphoma'''''||'''''Overview'''''||Sumire Kitahara, Derick Okwan (trainee)
| || ||
|
|
|SP
|PENDING
|
|
|
| ||
|
|
|
|
|-
|-
|     Enteropathy-Associated T-cell Lymphoma||Disease||Sumire Kitahara, Derick Okwan (trainee)
|'''''Mature T- and NK-cell Neoplasms'''''||'''''Overview'''''||
|
|
|
|SP
|PENDING
|
|
| ||Snehal Patel (SP)
|
|
|
|
|-
|-
|     Monomorphic  Epitheliotropic Intestinal T-cell Lymphoma||Disease||Sumire Kitahara
|T-cell Prolymphocytic Leukemia||Disease||Michelle Don
|
|
|
|SP
|PENDING
|PENDING
| ||SP
|
|
|
|
|-
|T-cell Large Granular Lymphocytic Leukemia||Disease||Michelle Don
|
|
|-
|     Intestinal T-cell  Lymphoma, Not Otherwise Specified (NOS)||Disease||Sumire Kitahara, Derick Okwan (trainee)
|
|
|SP
|PENDING
|PENDING
| ||SP
|
|
|
|
|-
|Chronic Lymphoproliferative Disorder of NK Cells||Disease||Michelle Don
|
|
|-
|    Indolent T-cell  Lymphoproliferative Disorder of the Gastrointestinal Tract||Disease||Sumire Kitahara, Derick Okwan (trainee)
|
|
|SP
|PENDING
|PENDING
|
| ||SP
|
|
|
|
|-
|-
|Hepatosplenic T-cell Lymphoma||Disease||Michelle Don
|Aggressive NK-cell Leukemia||Disease||
| ||SP
|PENDING
|
|
|
|
|
|
|-
|Subcutaneous Panniculitis-Like T-cell Lymphoma||Disease||
| ||SP
| ||SP
|
|
|
|-
|'''''EBV-Positive T-cell and NK-cell Lymphoproliferative Diseases of  Childhood'''''||'''''Overview'''''||
|
|
|
|
|
|
|-
|Mycosis Fungoides||Disease||
| ||SP
| ||SP
|
|
|
|
|-
|  Systemic EBV-Positive  T-cell Lymphoma of Childhood||Disease||Lisa Lansdon (trainee)
|
|
|
|
|-
|PENDING
|Sézary Syndrome||Disease||
| ||SP
| ||SP
|
|
|
|-
|   Chronic Active EBV  Infection of T- and NK-cell Type, Systemic Form||Disease||
|
|
|
|
|
|
|-
|'''''Primary Cutaneous CD30 Positive T-cell Lymphoproliferative  Disorders'''''||'''''Overview'''''||
| ||SP
| ||SP
|
|
|
|-
|    Hydroa  Vacciniforme-Like Lymphoproliferative Disorder||Disease||
|
|
|
|
|
|
|-
|    Lymphomatoid  Papulosis||Disease||
| ||SP
| ||SP
|
|
|
|
|
|
|-
|-
|    Primary Cutaneous Anaplastic Large Cell Lymphoma||Disease||
|    Severe Mosquito Bite Allergy||Disease||
| ||SP
|
|
|
|
|
| ||SP
|
|
|
|
|-
|-
|'''''Primary Cutaneous Peripheral T-cell Lymphomas, Rare Subtypes'''''||'''''Overview'''''||
|Adult T-cell Leukemia/Lymphoma||Disease||
| ||SP
|
|
|
|
|
| ||SP
|
|
|
|
|-
|-
|     Primary Cutaneous  Gamma Delta T-cell Lymphoma||Disease||
|Extranodal NK/T-cell Lymphoma, Nasal Type||Disease||
| ||SP
|
|
|
|
|
| ||SP
|
|
|
|
|-
|-
|     Primary Cutaneous  CD8+ Aggressive Epidermotropic Cytotoxic T-cell Lymphoma||Disease||
|'''''Intestinal T-cell Lymphoma'''''||'''''Overview'''''||Sumire Kitahara, Derick Okwan (trainee)
| ||SP
|
|
|
|PENDING
|
|
|SP
|
|
|
|
|-
|-
|     Primary Cutaneous  Acral CD8+ T-cell Lymphoma||Disease||
|     Enteropathy-Associated T-cell Lymphoma||Disease||Sumire Kitahara, Derick Okwan (trainee)
| ||SP
|
|
|
|
|Complete
|1/21/2021
|SP
|
|
|
|
|-
|-
|     Primary Cutaneous CD4+ Small/Medium T-cell Lymphoproliferative Disorder||Disease||
|     Monomorphic Epitheliotropic Intestinal T-cell Lymphoma||Disease||Sumire Kitahara
| ||SP
|
|
|
|PENDING
|
|
|SP
|
|
|
|
|-
|-
|Peripheral T-cell Lymphoma, Not Otherwise Specified (NOS)||Disease||
|     Intestinal T-cell Lymphoma, Not Otherwise Specified (NOS)||Disease||Sumire Kitahara, Derick Okwan (trainee)
| ||SP
|
|
|
|
|PENDING
|
|SP
|
|
|
|
|-
|-
|'''''Angioimmunoblastic T-cell Lymphoma and Other Nodal Lymphomas of T Follicular Helper Cell Origin'''''||'''''Overview'''''||
|    Indolent T-cell Lymphoproliferative Disorder of the Gastrointestinal Tract||Disease||Sumire Kitahara, Derick Okwan (trainee)
| ||SP
|
|
|
|PENDING
|
|
|SP
|
|
|
|
|-
|-
|     Angioimmunoblastic  T-cell Lymphoma||Disease||Ruthann Pfau, Sara Akhavanfard (trainee)
|Hepatosplenic T-cell Lymphoma||Disease||Michelle Don
|
|
|
|Complete
|1/21/2021
|SP
|SP
|PENDING
|
|
|
|
|-
|Subcutaneous Panniculitis-Like T-cell Lymphoma||Disease||
|
|
|-
|    Follicular T-cell  Lymphoma||Disease||Ruthann Pfau, Sara Akhavanfard (trainee)
|
|
|SP
|PENDING
|
|
| ||SP
|
|
|
|
|-
|-
|     Nodal Peripheral  T-cell Lymphoma with T Follicular Helper Phenotype||Disease||
|Mycosis Fungoides||Disease||Daynna Wolff, Jane Scribner (trainee)
| ||SP
|
|
|
|
|PENDING
| ||SP
|
|
|
|
|-
|-
|Anaplastic Large Cell Lymphoma, ALK-Positive||Disease||Sumire Kitahara
|Sézary Syndrome||Disease||Daynna Wolff, Madison Hannay (trainee)
|
|
|
|SP
|PENDING
|PENDING
|
| ||SP
|
|
|
|
|-
|-
|Anaplastic Large Cell Lymphoma, ALK-Negative||Disease||Sumire Kitahara
|'''''Primary Cutaneous CD30 Positive T-cell Lymphoproliferative  Disorders'''''||'''''Overview'''''||
|
|
|
|SP
|PENDING
|
|
| ||SP
|
|
|
|
|-
|-
|Breast Implant-Associated Anaplastic Large Cell Lymphoma||Disease||Sumire Kitahara
|    Lymphomatoid  Papulosis||Disease||
|
|
|
|SP
|PENDING
|
|
| ||SP
|
|
|
|
|-
|-
| || ||
|    Primary Cutaneous  Anaplastic Large Cell Lymphoma||Disease||
| ||
|
|
|
|
|
| ||SP
|
|
|
|
|-
|-
|'''''Hodgkin Lymphomas'''''||'''''Overview'''''||
|'''''Primary Cutaneous Peripheral T-cell Lymphomas, Rare Subtypes'''''||'''''Overview'''''||
| ||Associate Editor??
|
|
|
|
|
| ||SP
|
|
|
|
|-
|-
|Nodular Lymphocyte Predominant Hodgkin Lymphoma||Disease||
|     Primary Cutaneous  Gamma Delta T-cell Lymphoma||Disease||
| ||
|
|
|
|
|
| ||SP
|
|
|
|
|-
|-
|'''''Classic Hodgkin Lymphoma'''''||'''''Overview'''''||
|     Primary Cutaneous  CD8+ Aggressive Epidermotropic Cytotoxic T-cell Lymphoma||Disease||
| ||
|
|
|
|
|
| ||SP
|
|
|
|
|-
|-
|    Nodular Sclerosis Classic Hodgkin Lymphoma||Disease||
|     Primary Cutaneous Acral CD8+ T-cell Lymphoma||Disease||
| ||
|
|
|
|
|
| ||SP
|
|
|
|
|-
|-
|    Lymphocyte-Rich  Classic Hodgkin Lymphoma||Disease||
|     Primary Cutaneous  CD4+ Small/Medium T-cell Lymphoproliferative Disorder||Disease||
| ||
|
|
|
|
|
| ||SP
|
|
|
|
|-
|-
|    Mixed Cellularity  Classic Hodgkin Lymphoma||Disease||
|Peripheral T-cell Lymphoma, Not Otherwise Specified (NOS)||Disease||
| ||
|
|
|
|
|
| ||SP
|
|
|
|
|-
|-
|    Lymphocyte-Depleted Classic Hodgkin Lymphoma||Disease||
|'''''Angioimmunoblastic T-cell Lymphoma and Other Nodal Lymphomas of T Follicular Helper Cell Origin'''''||'''''Overview'''''||
| ||
|
|
|
|
|
| ||SP
|
|
|
|
|-
|-
|'''''Immunodeficiency-Associated Lymphoproliferative Disorders'''''||'''''Overview'''''||
|     Angioimmunoblastic  T-cell Lymphoma||Disease||Ruthann Pfau, Sara Akhavanfard (trainee)
| ||
|
|
|
|PENDING
|
|
|SP
|
|
|
|
|-
|-
|Lymphomas Associated with HIV Infection||Disease||
|    Follicular T-cell  Lymphoma||Disease||Ruthann Pfau, Sara Akhavanfard (trainee)
| ||
|
|
|
|PENDING
|
|
|SP
|
|
|
|
|-
|-
|'''''Post-Transplant Lymphoproliferative Disorders'''''||'''''Overview'''''||
|     Nodal Peripheral  T-cell Lymphoma with T Follicular Helper Phenotype||Disease||Hans Hamnvåg
| ||
|
|
|
|
|PENDING
| ||SP
|
|
|
|
|-
|-
|    Non-Destructive  Post-Transplant Lymphoproliferative Disorders||Disease||
|Anaplastic Large Cell Lymphoma, ALK-Positive||Disease||Sumire Kitahara
| ||
|
|
|
|
|PENDING
|
|SP
|
|
|
|
|-
|-
|    Polymorphic  Post-Transplant Lymphoproliferative Disorders||Disease||Anna Shestakova (trainee)''+,''
|Anaplastic Large Cell Lymphoma, ALK-Negative||Disease||Sumire Kitahara
 
Fabiola Quintero-Rivera
|
|
|
|
|PENDING
|PENDING
|
|
|SP
|
|
|
|
|-
|-
|'''''    Monomorphic  Post-Transplant Lymphoproliferative Disorders (B- and T/NK-cell Types)'''''||'''''Overview'''''||
|Breast Implant-Associated Anaplastic Large Cell Lymphoma||Disease||Sumire Kitahara
| ||
|
|
|
|PENDING
|
|
|SP
|
|
|
|
|-
|-
|          Monomorphic  B-cell PTLD||Disease||
| || ||
| ||
|
|
|
|
|
|
|
|-
|          Monomorphic  T/NK-cell PTLD||Disease||
| ||
| ||
|
|
|
|
|-
|'''''Hodgkin Lymphomas'''''||'''''Overview'''''||
|
|
|
|-
|    Classical Hodgkin  Lymphoma Post-Transplant Lymphoproliferative Disorder||Disease||
| ||
|
|
|
|
| ||Greg Corboy (GC)
|
|
|
|
|-
|-
|Other Iatrogenic Immunodeficiency-Associated Lymphoproliferative  Disorders||Disease||
|Nodular Lymphocyte Predominant Hodgkin Lymphoma||Disease||
| ||
|
|
|
|
|
| ||GC
|
|
|
|
|-
|-
|'''''Histiocytic and Dendritic Cell Neoplasms'''''||'''''Overview'''''||
|'''''Classic Hodgkin Lymphoma'''''||'''''Overview'''''||
| ||
|
|
|
|
|
| ||GC
|
|
|
|
|-
|-
|Histiocytic Sarcoma||Disease||
|    Nodular Sclerosis  Classic Hodgkin Lymphoma||Disease||
| ||
|
|
|
|
|
| ||GC
|
|
|
|
|-
|-
|'''''Tumors Derived From Langerhans Cells'''''||'''''Overview'''''||
|    Lymphocyte-Rich  Classic Hodgkin Lymphoma||Disease||
| ||
|
|
|
|
|
| ||GC
|
|
|
|
|-
|-
|   Langerhans Cell Histiocytosis||Disease||
|    Mixed Cellularity Classic Hodgkin Lymphoma||Disease||
| ||
|
|
|
|
|
| ||GC
|
|
|
|
|-
|-
|   Langerhans Cell Sarcoma||Disease||
|    Lymphocyte-Depleted Classic Hodgkin Lymphoma||Disease||
| ||
|
|
|
|
|
| ||GC
|
|
|
|
|-
|-
|Indeterminate Dendritic Cell Tumour||Disease||
|'''''Immunodeficiency-Associated Lymphoproliferative Disorders'''''||'''''Overview'''''||
| ||
|
|
|
|
|
| ||GC
|
|
|
|
|-
|-
|Interdigitating Dendritic Cell Sarcoma||Disease||
|Lymphomas Associated with HIV Infection||Disease||
| ||
|
|
|
|
|
| ||GC
|
|
|
|
|-
|-
|Follicular Dendritic Cell Sarcoma||Disease||
|'''''Post-Transplant Lymphoproliferative Disorders'''''||'''''Overview'''''||
| ||
|
|
|
|
|
| ||GC
|
|
|
|
|-
|-
|    Inflammatory Pseudotumor-Like Follicular/Fibroblastic Dendritic Cell Sarcoma||Disease||
|    Non-Destructive Post-Transplant Lymphoproliferative Disorders||Disease||
| ||
|
|
|
|
|
| ||GC
|
|
|
|
|-
|-
|Fibroblastic Reticular Cell Tumor||Disease||
|    Polymorphic  Post-Transplant Lymphoproliferative Disorders||Disease||Anna Shestakova (trainee)''+,''
| ||
 
Fabiola Quintero-Rivera
|
|
|
|PENDING
|
|
|GC
|
|
|
|
|-
|-
|Disseminated Juvenile Xanthogranuloma||Disease||
|'''''    Monomorphic  Post-Transplant Lymphoproliferative Disorders (B- and T/NK-cell Types)'''''||'''''Overview'''''||
| ||
|
|
|
|
|
| ||GC
|
|
|
|
|-
|-
|Erdheim-Chester Disease||Disease||
|          Monomorphic  B-cell PTLD||Disease||
| ||
|
|
|
|
|
| ||GC
|
|
|
|
|-
|-
| || ||
|          Monomorphic  T/NK-cell PTLD||Disease||
| ||
|
|
|
|
|
| ||GC
|
|
|
|
|-
|-
| || ||
|    Classical Hodgkin  Lymphoma Post-Transplant Lymphoproliferative Disorder||Disease||
| ||
|
|
|
|
|
| ||GC
|
|
|
|
|-
|-
| || ||
|Other Iatrogenic Immunodeficiency-Associated Lymphoproliferative  Disorders||Disease||
| ||
|
|
|
|
|
| ||GC
|
|
|
|
|-
|-
| || ||
|'''''Histiocytic and Dendritic Cell Neoplasms'''''||'''''Overview'''''||
| ||
|
|
|
|
|
| ||GC
|
|
|
|
|-
|-
| || ||
|Histiocytic Sarcoma||Disease||
| ||
|
|
|
|
|
| ||GC
|
|
|
|
|-
|-
| || ||
|'''''Tumors Derived From Langerhans Cells'''''||'''''Overview'''''||
| ||
|
|
|
|
|
| ||GC
|
|
|
|
|-
|-
| || ||
|   Langerhans Cell  Histiocytosis||Disease||
| ||
|
|
|
|
|
| ||GC
|
|
|
|
|-
|-
| || ||
|   Langerhans Cell  Sarcoma||Disease||
| ||
|
|
|
|
|
| ||GC
|
|
|
|
|-
|-
| || ||
|Indeterminate Dendritic Cell Tumour||Disease||
| ||
|
|
|
|
|
| ||GC
|
|
|
|
|-
|-
| || ||
|Interdigitating Dendritic Cell Sarcoma||Disease||
| ||
|
|
|
|
|
| ||GC
|
|
|
|
|-
|-
| || ||
|Follicular Dendritic Cell Sarcoma||Disease||
| ||
|
|
|
|
|
| ||GC
|
|
|
|
|-
|-
| || ||
|    Inflammatory  Pseudotumor-Like Follicular/Fibroblastic Dendritic Cell Sarcoma||Disease||
| ||
|
|
|
|
|
| ||GC
|
|
|
|
|-
|-
| || ||
|Fibroblastic Reticular Cell Tumor||Disease||
| ||
|
|
|
|
|
| ||GC
|
|
|
|
|-
|-
| || ||
|Disseminated Juvenile Xanthogranuloma||Disease||
| ||
|
|
|
|
|
| ||GC
|
|
|
|
|-
|-
| || ||
|Erdheim-Chester Disease||Disease||
| ||
|
|
|
|
|
| ||GC
|
|
|
|
|-
|-
| || ||
| || ||
| ||
|
|
|
|
|
| ||
|
|
|
|
|-
|-
| || ||
| || ||
| ||
|
|
|
|
|
| ||
|
|
|
|
|-
|-
| || ||
| || ||
| ||
|
|
|
|
|
| ||
|
|
|
|
|-
|-
| || ||
| || ||
| ||
|
|
|
|
|
| ||
|
|
|
|
|-
|-
| || ||
| || ||
|
|
|
| ||
| ||
|
|
|
|
|-
| || ||
|
|
|
|
|}
{| class="wikitable sortable"
|+Gene-Specific Pages
!'''Gene'''
!'''Author'''
!'''Associate Editor'''
!Author Content
(Pending or Complete)
!Editor Reviewed (Date)
!Notes
|-
|BCR
|Brian Davis
|
|
|Complete (8/10/18)
| ||
|
|
|
|
|-
|-
|ABL1
| || ||
|Brian Davis
|
|
|
|Complete (4/16/19)
|
| ||
|
|
|
|
|-
|-
|RUNX1
| || ||
|Brian Davis
|
|
|Complete (6/9/19)
|
|
|
|
|-
| ||
|RUNX1T1
|Brian Davis
|
|Complete (5/23/19)
|
|
|
|
|-
|-
|MYH11
| || ||
|Brian Davis
|
|
|Complete (8/6/18)
|
|
|
|
|-
| ||
|FLT3
|Kay Weng Choy
|
|Complete (
|
|
|
|
|-
|-
|NPM1
| || ||
|Kay Weng Choy
|
|
|Complete (
|
|
|
|
|-
| ||
|TP53
|Kay Weng Choy
|
|Complete (
|
|
|
|
|-
|-
|DNMT3A
| || ||
|Kay Weng Choy
|
|
|Complete (
|
|
|
|
|-
| ||
|CEBPA
|Gordana
|
|Complete (
|
|
|
|
|-
|-
|IDH1
| || ||
|Paul De Fazio
|
|
|Complete (
|
|
|
|
|-
| ||
|IDH2
|Paul De Fazio
|
|Complete (
|
|
|
|
|-
|-
|PML
| || ||
|Brian Davis
|
|
|Complete (12/5/18)
|
|
|
|
|-
| ||
|RARA
|Brian Davis
|
|Complete (8/3/18)
|
|
|
|
|-
|-
|ETV6
| || ||
|Brian Davis
|
|
|Complete (6/9/19)
|
|
|
|
|-
| ||
|KIT
|Brian Davis
|
|Complete (10/1/18)
|
|
|
|
|-
|-
|CBFB
| || ||
|Brian Davis
|
|
|Complete (8/2/18)
|
|
|
|
|-
| ||
|GATA2
|Kay Weng Choy
|
|Complete (
|
|
|
|
|-
|-
|PTEN
| || ||
|Beth Pitel
|
|Pending
|
|
|-
|MLTT3
|
|
|
|
|
|
| ||
|
|
|
|
|-
|-
|MECOM
| || ||
|Brian Davis
|
|
|Pending
|
|
|
|
|-
| ||
|FGFR1(FLT2)
|Brian Davis
|
|Pending
|
|
|
|
|-
|-
|KMT2A
| || ||
|
|
|
|
|
|
| ||
|
|
|
|
|-
|-
|DEK
| || ||
|
|
|
|
|
|
| ||
|
|
|
|
|-
|-
|NUP214
| || ||
|
|
|
|
|
|
| ||
|
|
|
|
|}
{| class="wikitable sortable"
|+Gene-Specific Pages
!'''Gene'''
!'''Author'''
!'''Date Assigned to Author'''
!'''Target Completion Date'''
!'''Author Content (Pending or Complete)'''
!'''Date Completed by Author'''
!'''Associate Editor'''
!'''Date of Last Editor Review'''
!'''Notes'''
|-
|-
|RBM15
|BCR
|Brian Davis
|
|
|
|
|Complete
|8/10/18
|
|
|
|
|
|
|-
|-
|MKL1
|ABL1
|Brian Davis
|
|
|
|
|Complete
|4/16/19
|
|
|
|
|
|
|-
|-
|DDX41
|RUNX1
|Brian Davis
|
|
|
|
|Complete
|6/9/19
|
|
|
|
|
|
|-
|-
|ANKRD26
|RUNX1T1
|Brian Davis
|
|
|
|
|Complete
|5/23/19
|
|
|
|
|
|
|-
|-
|CUX1
|MYH11
|Brian Davis
|
|
|
|
|Complete
|8/6/18
|
|
|
|
|
|
|-
|-
|TET2
|FLT3
|Kay Weng Choy
|
|
|
|Complete
|
|
|
|
Line 2,120: Line 2,276:
|
|
|-
|-
|EZH2
|NPM1
|Kay Weng Choy
|
|
|
|Complete
|
|
|
|
Line 2,127: Line 2,286:
|
|
|-
|-
|FOXP1
|TP53
|Kay Weng Choy
|
|
|
|Complete
|
|
|
|
Line 2,134: Line 2,296:
|
|
|-
|-
|MYC
|DNMT3A
|Kay Weng Choy
|
|
|
|Complete
|
|
|
|
Line 2,141: Line 2,306:
|
|
|-
|-
|JAK2
|CEBPA
|Gordana
|
|
|
|Complete
|
|
|
|
Line 2,148: Line 2,316:
|
|
|-
|-
|WT1
|IDH1
|Paul De Fazio
|
|
|
|Complete
|
|
|
|
Line 2,155: Line 2,326:
|
|
|-
|-
|CBL
|IDH2
|Paul De Fazio
|
|
|
|Complete
|
|
|
|
Line 2,162: Line 2,336:
|
|
|-
|-
|NF1
|PML
|Brian Davis
|
|
|
|
|Complete
|12/5/18
|
|
|
|
|
|
|-
|-
|SUZ12
|RARA
|Brian Davis
|
|
|
|
|Complete
|8/3/18
|
|
|
|
|
|
|-
|-
|ERG
|ETV6
|Brian Davis
|
|
|
|
|Complete
|6/9/19
|
|
|
|
|
|
|-
|-
|EST2
|KIT
|Brian Davis
|
|
|
|
|Complete
|10/1/18
|
|
|
|
|
|
|-
|-
|RPS14
|CBFB
|Brian Davis
|
|
|
|
|Complete
|8/2/18
|
|
|
|
|
|
|-
|-
|RB1
|GATA2
|Kay Weng Choy
|
|
|
|Complete
|
|
|
|
Line 2,204: Line 2,396:
|
|
|-
|-
|MPL
|PTEN
|Beth Pitel
|
|
|
|Pending
|
|
|
|
Line 2,211: Line 2,406:
|
|
|-
|-
|CHGA
|MLTT3
|
|
|
|
|
|
|
|
|-
|CDH1
|
|
|
|
Line 2,225: Line 2,416:
|
|
|-
|-
|SRSF2
|MECOM
|Brian Davis
|
|
|Pending
|
|
|
|
|-
|FGFR1(FLT2)
|Brian Davis
|
|
|Pending
|
|
|
|
|-
|KMT2A
|
|
|
|
|
|
|
|
|-
|DEK
|Wahab A. Khan
|
|
|
|
|Pending
|
|
|
|
|
|
|-
|DNMT1
|
|
|
|-
|
|NUP214
|
|Wahab A. Khan
|
|
|-
|
|PRDX2
|Pending
|
|
|
|
|-
|RBM15
|
|
|
|
|
|
|
|
|-
|MKL1
|
|
|
|
|
|
|
|
|-
|DDX41
|Ying Zou
|8/7/20
|
|Pending
|
|
|
|
|-
|ANKRD26
|
|
|
|
|
|
|
|
|-
|CUX1
|
|
|
|
|
|
|
|
|-
|TET2
|
|
|
|
|
|
|
|
|-
|EZH2
|
|
|
|
|
|
|
|
|-
|FOXP1
|
|
|
|
|
|
|
|
|-
|MYC
|
|
|
|
|
|
|
|
|-
|JAK2
|
|
|
|
|
|
|
|
|-
|WT1
|DONE
|
|
|DONE
|
|
|
|
|-
|CBL
|
|
|
|
|
|
|
|
|-
|NF1
|
|
|
|
|
|
|
|
|-
|SUZ12
|
|
|
|
|
|
|
|
|-
|ERG
|
|
|
|
|
|
|
|
|-
|EST2
|
|
|
|
|
|
|
|
|-
|RPS14
|
|
|
|
|
|
|
|
|-
|RB1
|
|
|
|
|
|
|
|
|-
|MPL
|
|
|
|
|
|
|
|
|-
|CHGA
|
|
|
|
|
|
|
|
|-
|CDH1
|
|
|
|
|
|
|
|
|-
|SRSF2
|
|
|
|
|
|
|
|
|-
|DNMT1
|
|
|
|
|
|
|
|
|-
|PRDX2
|
|
|
|
|
|
|
|
|-
|ASXL1
|DONE
|
|
|DONE
|
|
|
|
|-
|MN1
|
|
|
|
|
|
|
|
|-
|SF3A1
|
|
|
|
|
|
|
|
|-
|EP300
|
|
|
|
|
|
|
|
|-
|JARID2
|
|
|
|
|
|
|
Line 2,246: Line 2,756:
|
|
|-
|-
|ASXL1
|BRCA1
|
|
|
|
|
|
|
|
|-
|MN1
|
|
|
|
Line 2,260: Line 2,766:
|
|
|-
|-
|SF3A1
|BRCA2
|
|
|
|
|
|
|
|
|-
|EP300
|
|
|
|
|
|-
|JARID2
|
|
|
|
Line 2,284: Line 2,779:
|
|
|
|
|
|
|
|-
|
|
|
|
Line 2,298: Line 2,789:
|
|
|
|
|
|
|
|-
|
|
|
|
Retrieved from "https://test.ccga.io/index.php/Volunteer_Assignments_and_Opportunities"